Company profile
Orthofix Medical Inc.
NASDAQ: OFIX · Healthcare · Medical - Devices
#172 of 1,418 Healthcare companies by revenue46th-percentile growth
EA Score
75B+FH 69DQ 87GM 62SS 86
v0.1 · 65/100 weight · provisional
↑ listing tenure, disclosure history · ↓ revenue growth (YoY), balance-sheet leverage
Methodology →Revenue TTM
$825.4M
Rev growth YoY (TTM)
+2.6%
Net income (FY)
-$92.2M
Employees
1,605
as of 2026-08-12
Market cap
$417.2M
as of 2026-08-12
Financials — latest annual
SEC EDGAR · USD-normalizedConceptUSDNativeFY
Revenue$822.3M$822.3M2025
Net income-$92.2M-$92.2M2025
Operating income-$81.4M-$81.4M2025
Total assets$850.6M$850.6M2025
Liabilities$400.6M$400.6M2025
Equity$450.0M$450.0M2025
Revenue trend
FY2019 – FY2025 · USD
FY19
FY19
FY20
FY21
FY22
FY23
FY24
FY25
Revenue by segment
Filed disclosures · FY2025
By product
Global Spine100%
By geography
Other Countries61%
ITALY18%
FRANCE10%
GERMANY7%
BRAZIL4%
The read
What is Orthofix Medical Inc.’s revenue?
Orthofix Medical Inc. booked $822.3M in FY2025 revenue, growing 2.9% year over year — about the middle of the pack among Healthcare companies we track, at a -11.2% net margin.
Peers · Healthcare
Verano Holdings Corp59CArrowhead Pharmaceuticals, Inc.76B+Myriad Genetics, Inc.67BTilray Brands, Inc.52DCaris Life Sciences, Inc.61CGoodRx Holdings, Inc.68BNeighbors
Denton →Key facts
CEOMassimo Calafiore
SectorHealthcare
IndustryMedical - Devices
HeadquartersLewisville, TX
ExchangeNASDAQ: OFIX
Employees1,605
IPO date1992-04-24
Financials: SEC EDGAR (XBRL), USD-normalized per IAS 21 · TTM/quarterly + segments: FMP from filed disclosures · Filings: EDGAR submissions. County headcount and EA Score are in progress — see docs/DATA_GAPS.md.